Bepirivirsen Offers Hope for Hepatitis B Cure

A breakthrough drug called bepirovirsen is paving the way for a “functional cure” of hepatitis B—letting some patients stop treatment without the virus returning. Unlike current therapies that merely suppress the virus, this drug attacks its genetic material and key proteins while boosting the immune system. Early results show promise, with patients thriving for up to three years, though responses vary and long-term effects are still being studied. Mild side effects have been reported, and trials haven’t included those with advanced liver disease. Regulatory decisions in major markets are expected by October—potentially transforming care for millions. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/71e126d6e90bfd4b